Table 2 Baseline clinical characteristics of DR-TB patients on second line anti-TB treatment in Amhara region, Ethiopia
Variables | Frequency | Percent |
|---|---|---|
Sputum smear | ||
 Positive | 400 | 78.5 |
 Negative | 108 | 21.5 |
BMI | ||
  < 18.5 | 388 | 76.4 |
  ≥ 18.5 | 120 | 23.6 |
Co-existing diabetes | ||
 Yes | 16 | 3.1 |
 No | 492 | 96.9 |
CKD | ||
 Yes | 7 | 1.4 |
 No | 501 | 98.6 |
HIV | ||
 Positive | 123 | 24.2 |
 Negative | 385 | 75.8 |
COPD | ||
 Yes | 88 | 17.32 |
 No | 420 | 82.68 |
Hemoglobin status | ||
 Anemic | 392 | 77.2 |
 Non anemic | 116 | 22.8 |
HTN | ||
 Yes | 15 | 2.9 |
 No | 493 | 97.1 |
Previous TB treatment | ||
 Yes | 404 | 79.5 |
 No | 104 | 20.5 |
Resistant type | ||
 R or H | 288 | 56.7 |
 MDR | 220 | 43.3 |
TB type | ||
 Pulmonary | 447 | 88.0 |
  Disseminate | 61 | 12.0 |
Cigarette smoker | ||
 Yes | 72 | 14.2 |
 No | 436 | 85.8 |